Beckett, A. H. et al., “Buccal absorption of basis drugs and its application as an in vivo model of passive drug transfer through lipid membranes”, J. Pharm. Pharmac., 19 Suppl, 1967, pp 31S-41S. |
David S. Weinberg et al. “Sublingual absorption of selected opioid analgesics”, Clin. Pharmacol Ther., 1998, vol. 44, pp. 335-342. |
U.S. patent application Ser. No. 09/286,818, filed Apr. 6, 1999. |
U.S. patent application Ser. No. 09/421,905, filed Oct. 20, 1999. |
U.S. patent application Ser. No. 09/510,878, filed Feb. 23, 2000. |
U.S. patent application Ser. No. 09/535,458, filed Mar. 24, 2000. |
U.S. patent application Ser. No. 09/592,400, filed Jun. 13, 2000. |
U.S. patent application Ser. No. 09/618,808, filed Jul. 18, 2000. |
U.S. patent application Ser. No. 09/631,326, filed Aug. 3, 2000. |
U.S. patent application Ser. No. 09/671,552, filed Sep. 27, 2000. |
U.S. patent application Ser. No. 09/714,571, filed Nov. 16, 2000. |
U.S. patent application Ser. No. 09/759,561, filed Jan. 11, 2001. |
U.S. patent application Ser. No. 09/759,838, filed Jan. 11, 2001. |
U.S. patent application Ser. No. 09/681,935, filed Jun. 28, 2001. |
U.S. patent application Ser. No. 09/924,914, filed Aug. 8, 2001. |
U.S. patent application Ser. No. 09/955,870, filed Sep. 19, 2001. |
U.S. patent application Ser. No. 09/956,445, filed Sep. 19, 2001. |
U.S. patent application Ser. No. 09/990,628, filed Nov. 13, 2001. |
U.S. patent application Ser. No. 09/992,122, filed Nov. 13, 2001. |
U.S. patent application Ser. No. 10/024,631, filed Dec. 17, 2001. |
U.S. patent application Ser. No. 10/044,113, filed Jan. 9, 2002. |
“Flavor Encapsulation Technologies, Flavor Unit Sweet, Product Management”, H&R (undated) (published at least before Nov. 27, 1996), 25 pages. |
Dr. Massimo Calanchi and Dr. Sam Ghanta, “Taste-masking of oral formulations”, Eurand International SpA, Pharmaceutical Manufacturing International, 1996 (5 pages). |
The Eurand Group, Brochure (undated) (published at least before Nov. 27, 1996), (16 pages). |
Merck Index, 11th Ed., #1635 “Caffeine” (1989), p. 248. |
Merck Index, 12th Ed., #2337 “Cimetidine” (1996), p. 383. |
Merck Index, 12th Ed., #3264 “Dimethicone” (1996), p. 544. |
Merck Index, 12th Ed., #3972 “Famotidine” (1996), p. 667. |
Merck Index, 12th Ed., #6758 “Nizatidine” (1996), p. 1143. |
Merck Index, 12th Ed., #6977 “Omeprazole” (1996), p. 1174. |
Merck Index, 12th Ed., #8272 “Rabeprazole” (1996), p. 1392. |
Merck Index, 12th Ed., #8286 “Ranitidine” (1996), p. 1395. |
James G. Elliott, “Application of Antioxidant Vitamins in Foods and Beverages” Food Technology, (Feb., 1999), pp. 46-48. |
C. Curtis Vreeland, “Nutraceuticals Fuel Confectionery Growth” Candy R&D, (Mar., 1999), pp. 29, 31-32, 34-35. |
Kitty Broihier, R.D., “Foods of Tomorrow, Milking The Nutrition Market”, Food Processing, (Mar., 1999), pp. 41, 42 and 44. |
Kitty Broihier, R.D., “Tea Time For Nutraceuticals, New Black, Green Tea Products Brew Up a Bevy Of Health Benefits”, Food Processing; (Mar., 1999), pp. 59, 61 and 63. |
Andrea Allen, Jack Neff, Lori Dahm and Mary Ellen Kuhn, “Exclusive Guide to Wellness Foods and Nutraceuticals”, Food Processing (Special Supplement), (Mar., 1999). |
Product package “Aspergum” distributed by Heritage Consumer Products, LLC (on sale prior to Nov. 27, 1995). |
Product package “Chew & Sooth Zinc Dietary Supplement Gum” by Gumtech International, Inc., undated but prior to Dec. 22, 2000. |
Product package “Dental Care the Baking Soda Gum” distributed by Church & Dwight Co., Inc. (1998). |
Product package “BreathAsure Dental Gum” distributed by Breath Asure, Inc. (1998). |
Product package “Trident Advantage with Baking Soda” distributed by Warner-Lambert Co. (1998). |
Product package “CHOOZ Antacid/Calcium Supplement with Calcium Carbonate” distribute by Heritage Consumer Products Co., undated but prior to Dec. 22, 2000. |
Hertiage Consumer Products Co. article from the Internet “Cosmetics and Toiletries, The Heritage Story”, printed Jul. 20, 2000, <http://www.cnewsusa.com/Connecticut/14997,html>, 1 page. |
The United States Pharmacopeia The National Formulary—“General Information”, dated Jan. 1, 1990 pp 1624-1625 and pp 1696-1697. |
Gumtech article from the Internet “Customized Solutions For Customer Brands”, printed Oct. 18, 2000,<http://www.gum-tech.com/cus-brands.html>, 3 pages. |
Product package for Stay Alert Caffeine Supplement Gum, distributed by Amurol Confections Company (first quarter 1998). |
Rabeprazole article from the Internet “Rabeprazole: Pharmacokinetics and Safety in the Elderly”, printed Sep. 22, 2000,<http://www.mmhc.com/cg/articles/CG9905/Hum-phries.html>, 2 pages. |
Brochure for “Minerals Technologies Specialty Minerals”, 1998, 19 pages. |
Akitoshi et al., Abstract “Acceleration of Transdermal Absorption of Pharmaceuticals by Essential Oils and Organic Solvents,” Chem. Abst., 112:125228t, 1990. |
Bradford, A Rapid and Sensitive Method for the Quantification of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Analytical Biochemistry, 72:248-254 (1976). |
Nielsen et al., P-Glycoprotein as Multidrug Transporter: A Critical Review of Current Multidrug Resistant Cell Lines, Chimica et Biophysica Acta., 1139:169-183 (1992). |
Adams, M.W., d-Alpha Tocopheryl Polyethylene glycol 1000 Succinate (Eastman vitamin E TPGS) as an Emulsifier and Bioenhancer for Drugs and Lipophilic Compounds, 6th International Conference on Pharmaceutical Technology, Paris, Jun. 2-4, 1992. |
Chang, Tammy et al., “The Effect of Water-Soluble Vitamin E on Cyclosporine Pharmacokinetics in Healthy Volunteers,” Abstract in American Society to Clinical Pharmacology and Therapeutics, 57(2):163, Feb. 1995. |
Hebert, Mary F. et al.; “Bioavailability of Cyclosporine with Concomitant Rifampin Administration is Markedly Less Than Predicted by Hepatic Enzyme Induction” (1992) Clin. Pharmacol. Ther. 52:453-457. |
Kronbach, Thomas et al.; “Oxidation of Midazolam and Triazolam by Human Liver Cytochrome P450IIIA4”(1989) Molec. Pharm. 36:89-96. |
Lalka et al.; “The Hepatic First-Pass Metabolism of Problematic Drugs” (1993) J. Clin. Pharmacol. 33:657-669. |
Lum et al.; “Clinical Trials of Modulation of Multidrug Resistance. Pharmacokinetic and Pharmacodynamic Considerations” (1993) Cancer 72:3502-3514. |
Muranishi, Shozo; “Absorption Enhancers” (1990) Crit. Rev. Ther. Drug Carrier Sys. 7:1-33. |
Somberg et al.; “The Clinical Implications of First-Pass Metabolism: Treatment Strategies for the 1990's” (1993) J. Clin. Pharmacol. 33:670-673. |
Tam, Yun K.; “Individual Variation in First-Pass Metabolism” (1993) Clin. Pharmacokinet. 25:300-328. |
Van Hoogdalem et al.; “Intestinal Drug Absorption Enhancement: An Overview” (1989) Pharmacol. Ther. 44:407-443. |
Warren et al.; “Increased Accumulation of Drugs in Multidrug-Resistant Cell Induced by Liposomes” (1992) Cancer Research 52:3241-3245. |
Watkins, Paul B.; “The Role of Cytochromes P-450 in Cyclosporine Metabolism” (1990) J. Am. Acad. Dermacol. 23:1301-1309. |
Wrighton et al.; “In Vitro Methods for Assessing Human Hepatic Drug Metabolism: Their Use in Drug Development” (1993) 25:453-484. |
Wu et al.; “Use of IV and Oral Drug Levels from Cyclosporene (CsA) with Concomitant Rifampin to Differentiate Gut Absorption and Metabolism” (1993) Pharm. Res. 10:abstract ppdm8185. |
Zamora et al.; “Physical-Chemical Properties Shared by Compounds that Modulate Multidrug Resistance in Human Loukemic Cells” (1988) Molec. Pharmacol. 33:454-462. |
U.S. patent application Ser. No. 09/651,514, filed Aug. 30, 2000. |
U.S. patent application Ser. No. 09/552,290, filed Apr. 19, 2000. |
U.S. patent application Ser. No. 09/591,256, filed Jun. 9, 2000. |
U.S. patent application Ser. No. 09/621,780, filed Jul. 21, 2000. |
U.S. patent application Ser. No. 09/621,643, filed Jul. 21, 2000. |
U.S. patent application Ser. No. 09/654,464, filed Sep. 1, 2000. |
U.S. patent application Ser. No. 09/653,669, filed Sep. 1, 2000. |
U.S. patent application Ser. No. 09/748,699, filed Dec. 22, 2000. |
U.S. patent application Ser. No. 09/747,323, filed Dec. 22, 2000. |
U.S. patent application Ser. No. 09/749,983, filed Dec. 27, 2000. |